tinyBuild, Inc. (LON:TBLD)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-20.52	-62.54	11.55	8.27	4.94
Depreciation & Amortization	3.91	5.27	4.74	1.78	1.06
Other Amortization	10.5	10.65	5.79	3.5	4.5
Loss (Gain) From Sale of Assets	-0.9	-0.63	-11.13	-	-
Asset Writedown & Restructuring Costs	13.66	48.06	11.17	0.28	-
Stock-Based Compensation	0.15	0.41	1.73	2.45	5.85
Provision & Write-off of Bad Debts	1.81	0.09	-	-	-
Other Operating Activities	-0.07	-2.43	3.87	-0.04	0.54
Change in Accounts Receivable	3.88	12.4	-14.32	-8.84	-1.81
Change in Accounts Payable	-6.13	-0.4	5.89	5.2	2.27
Operating Cash Flow	6.29	10.88	19.27	13.29	16.47
Operating Cash Flow Growth	-42.18%	-43.54%	44.98%	-19.31%	40.38%
Capital Expenditures	-0.02	-0.18	-1.18	-	-0.02
Cash Acquisitions	-	-1.23	-	-11.78	-
Sale (Purchase) of Intangibles	-16.72	-31.9	-39.94	-25.87	-7.12
Investing Cash Flow	-16.74	-33.31	-41.12	-37.66	-7.14
Short-Term Debt Issued	-	-	-	-	0.18
Total Debt Issued	-	-	-	-	0.18
Short-Term Debt Repaid	-	-	-	-0.01	-
Long-Term Debt Repaid	-0.3	-0.53	-0.37	-0.1	-0.2
Total Debt Repaid	-0.3	-0.53	-0.37	-0.11	-0.2
Net Debt Issued (Repaid)	-0.3	-0.53	-0.37	-0.11	-0.02
Issuance of Common Stock	12.3	-	0.03	46.99	-
Repurchase of Common Stock	-0.07	-1.03	-	-	-
Other Financing Activities	-0.89	-	-0.15	-	-
Financing Cash Flow	11.04	-1.56	-0.49	46.89	-0.02
Net Cash Flow	0.59	-24	-22.34	22.52	9.3
Free Cash Flow	6.27	10.7	18.09	13.29	16.45
Free Cash Flow Growth	-41.41%	-40.85%	36.10%	-19.19%	40.29%
Free Cash Flow Margin	18.06%	23.96%	28.58%	25.48%	43.68%
Free Cash Flow Per Share	0.02	0.05	0.09	0.07	0.09
Cash Income Tax Paid	0.33	1.47	1.14	4.3	3.12
Levered Free Cash Flow	-15.67	-34.57	-24.42	-7.46	10.36
Unlevered Free Cash Flow	-15.66	-34.55	-24.39	-7.45	10.37
Change in Net Working Capital	0.07	-11.9	6.5	0.01	-1.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.